I’m sure that some of the recent news isn’t helping:
While cancer drug development is booming, the proportion of patients willing or able to take part in research has remained stuck for years at 5 percent to 10 percent.
That’s putting medical progress into jeopardy, researchers say. Some clinical trials of new drugs take much too long to complete or are simply cut short before enough data can be collected.
